Evaluation of the cost-utility of orlistat (Xenical) in the United Kingdom

被引：1
|
作者：
McEwan, P
Jones, M
Farina, C
Currie, CJ
机构：
[1] Univ Wales Coll Cardiff, Cardiff, S Glam, Wales
[2] Roche Prod Ltd, Welwyn Garden City, Herts, England
[3] Cardiff Res Consortium, Cardiff, S Glam, Wales
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65900-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：721 / 721
页数：1
相关论文
共 50 条
  • [31] A COST-UTILITY ANALYSIS OF EVEROLIMUS PLUS EXEMESTANE FOR THE TREATMENT OF ER+HER2-METASTATIC BREAST CANCER IN THE UNITED KINGDOM
    Taylor, M.
    Lewis, L.
    Vieira, J.
    Chandiwana, D.
    VALUE IN HEALTH, 2013, 16 (07) : A416 - A416
  • [32] COST-UTILITY ANALYSIS IN THE EVALUATION OF PERINATAL HEALTH-CARE
    DERHAM, R
    LANCET, 1986, 2 (8503): : 399 - 399
  • [33] EVALUATION OF THE COST-UTILITY OF THE YORK FAECAL CALPROTECTIN CARE PATHWAY
    Holmes, H.
    McMaster, J.
    Turvill, J.
    Davies, H.
    Vaines, V.
    VALUE IN HEALTH, 2019, 22 : S622 - S622
  • [34] EVALUATION OF STRATEGIES FOR THE PHYSICAL ACTIVITY PROMOTION: COST-UTILITY STUDY
    Sposito, L. A. C.
    Nakamura, P. M.
    Monteiro, H. L.
    Papini, C. B.
    Benedetti, T. R. B.
    Kokubun, E.
    REVISTA INTERNACIONAL DE MEDICINA Y CIENCIAS DE LA ACTIVIDAD FISICA Y DEL DEPORTE, 2021, 21 (83): : 607 - 621
  • [35] Prospective evaluation of cost of ERCP in the United Kingdom
    Larkin, CJ
    Irvine, R
    Gibson, L
    Tham, TCK
    GASTROINTESTINAL ENDOSCOPY, 1999, 49 (04) : AB144 - AB144
  • [36] Economic evaluation of drug eluting stents: Cost-utility analysis
    Bischof, M.
    Briel, M.
    Bucher, H. C.
    Nordmann, A.
    VALUE IN HEALTH, 2006, 9 (06) : A354 - A354
  • [37] Economic Evaluation of Stiripentol for Dravet Syndrome: A Cost-Utility Analysis
    Jesse Elliott
    Bláthnaid McCoy
    Tammy Clifford
    George A. Wells
    Doug Coyle
    PharmacoEconomics, 2018, 36 : 1253 - 1261
  • [38] Economic Evaluation of Stiripentol for Dravet Syndrome: A Cost-Utility Analysis
    Elliott, Jesse
    McCoy, Blathnaid
    Clifford, Tammy
    Wells, George A.
    Coyle, Doug
    PHARMACOECONOMICS, 2018, 36 (10) : 1253 - 1261
  • [39] Evaluation of the Cost-Utility of the York Faecal Calprotectin Care Pathway
    Holmes, Hayden
    McMaster, Jessica
    Davies, Heather
    Vaines, Victoria
    Turvill, James
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (03) : 521 - 528
  • [40] COST-UTILITY ANALYSIS IN UROLOGY
    Fero, Katherine
    Sharma, Vidit
    Lec, Patrick
    Saigal, Christopher
    Chamie, Karim
    JOURNAL OF UROLOGY, 2021, 206 : E435 - E436
12345